4), iv6iv14 (2006)
Novo Nordisk and Eli Lilly have been slower to pursue addiction indications for the medicines, while running trials proving their cardiovascular benefits, effects on kidney disease, heart failure and sleep apnea
Peter Balazs, a hormone and weight loss specialist in New York and New Jersey, shared that the most important shift is likely to label GLP-1 drugs as "multi-system metabolic modulators" rather than "simple weight loss drugs." MORE AMERICANS MAY BE CLASSIFIED AS OBESE UNDER NEW DEFINITION, STUDY SUGGESTS "The treatment goal is no longer just BMI reduction, but total cardiometabolic risk mitigation, with effects now documented across the liver, heart, kidneys and vasculature," he said
Although rare, there are potentially serious side effects when taking topiramate for weight loss
One drawback of gummy vitamins, however, is that they typically contain smaller doses of nutrients than tablets or capsules